Trials / Sponsors / Generate Biomedicines
Generate Biomedicines
Industry · 6 registered clinical trials — 3 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | Study of GB-4362 With Enfortumab Vedotin and Pembrolizumab for Advanced Urothelial Cancer Advanced Urothelial Cancer, Metastatic Urothelial Carcinoma | Phase 1 | 2026-04-01 |
| Recruiting | A Study to Investigate GB-0895 Adjunctive Therapy in Adults and Adolescents With Severe Uncontrolled Asthma (S Severe Asthma | Phase 3 | 2026-01-20 |
| Recruiting | A Study to Investigate GB-0895 Adjunctive Therapy in Adults and Adolescents With Severe Uncontrolled Asthma (S Severe Asthma | Phase 3 | 2025-12-03 |
| Active Not Recruiting | Study to Investigate the Safety, Tolerability, and Pharmacokinetics of GB-7624 in Healthy Adult Participants Atopic Dermatitis (AD) | Phase 1 | 2025-03-27 |
| Active Not Recruiting | A Study to Investigate GB-0895 in Adults With Mild to Moderate Asthma or COPD Asthma, COPD (Chronic Obstructive Pulmonary Disease) | Phase 1 | 2023-12-12 |
| Completed | Study to Investigate the Safety, Tolerability, and Pharmacokinetics of GB-0669 in Healthy Adult Participants SARS CoV-2 | Phase 1 | 2023-07-18 |